New therapy for Huntington’s disease gets £35 million boost
Drug Discovery World
OCTOBER 4, 2024
LoQus23 was founded in 2019 by Entrepreneurs in Residence at DDF Dr David Reynolds, Dr Caroline Benn, and Dr Ruth McKernan CBE, FMedSci and seeded by SV’s Dementia Discovery Fund. The financing round was led by Forbion, alongside existing investors SV Health Investors’ Dementia Discovery Fund (DDF) and Novartis Venture Fund (NVF).
Let's personalize your content